東陽光(600673.SH):子公司簽署建設工程施工合同 合同價款5589.3萬元
格隆匯 7 月 28日丨東陽光(600673.SH)公佈,公司控股子公司宜昌東陽光製藥有限公司擬委託關聯公司宜都山城水都建築工程有限公司進行東陽光創新藥、仿製藥一期項目合成車間5、合成車間6、合成車間8建築工程的建設工程施工,合同價款合計人民幣約5589.3萬元。
東陽光創新藥仿製藥一期項目合成車間5、合成車間6、合成車間8建築工程的建設工程施工,工程地點為枝城鎮樓子河村。工程施工內容包括以下:工程項目圖紙內的樁基、基礎土石方、土建、裝飾裝修、水電安裝工程(除機電設備安裝工程外)、消防工程等工程的全部工程施工、竣工驗收、工程質量保修等內容。含大型機械設備進出場費和場外運輸費、所有工程材料的保管及抽樣送檢、試塊的製作送檢、施工配合費、雨季施工和趕工增加費用、工程質量保修費用、文明安全施工措施費用、夜間施工及趕工措施費用、以及完成工程所需的所有措施費。並負責參加工程竣工驗收和在質量保修期內承擔工程質量保修責任。
此次交易屬於宜昌製藥公司生產經營建設需求,為擴大產能及後續儲備產品上市提供保障,符合公司及東陽光藥發展規劃和業務發展需要,定價公允、合理,有利於提高公司的競爭力,不存在損害公司及全體股東利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.